Evidence map›Paper›PMID 42195263›Full record

ArticleLife (Basel, Switzerland)2026

Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study.

Humera Banu, Eyad Al Shammari, Husam Qanash, Mitesh Patel, Mohd Adnan, Syed Shahanawaz, Mohammad Idreesh Khan, Malak Yahia Qattan, Syed Amir Ashraf

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Humera BanuDepartment of Clinical Nutrition, College of Applied Medical Sciences, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia.ORCID 0000-0002-2452-3493
Eyad Al ShammariDepartment of Clinical Nutrition, College of Applied Medical Sciences, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia.ORCID 0000-0003-2670-4607
Husam QanashDepartment of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha'il, Ha'il 55476, Saudi Arabia.ORCID 0000-0002-3068-0313
Mitesh PatelDepartment of Bioinformatics, Faculty of Engineering and Technology, Marwadi University, Rajkot 360003, Gujarat, India.ORCID 0000-0002-9283-2124
Mohd AdnanDepartment of Biology, College of Science, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia.ORCID 0000-0002-7080-6822
Syed ShahanawazDepartment of Physical Therapy, College of Applied Medical Sciences, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia.
Mohammad Idreesh KhanDepartment of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, P.O. Box 6666, Buraydah 51452, Saudi Arabia.ORCID 0000-0001-9325-6491
Malak Yahia QattanDepartment of Health Sciences, College of Applied Studies, King Saud University, P.O. Box 4545, Riyadh 11451, Saudi Arabia.
Syed Amir AshrafDepartment of Clinical Nutrition, College of Applied Medical Sciences, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia.ORCID 0000-0002-5333-9505

Funding

Scientific Research Deanship at University of Ha'il-Saudi Arabia RG-23 134
6 · The paper itself

Abstract

This study aims to investigate the potential anticancer effects of erucin, an isothiocyanate derived from

Indexed as

apoptosiscell cycle arrestEruca sativaerucinisothiocyanatesMDA-MB-231 cells

Identifiers

PMID42195263
PMCPMC13208285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.